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Summary
Pancreatic islets, also called islets of Langerhans, are clusters of (3 -cells that
produce glucose-level-controlling insulin. If the body has an autoimmune response to
these (3 -cells and begins destroying them, Type I diabetes (insulin-dependent) results.
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Transplantation of healthy islets into the body has been a measure that has proven to be
successful at treating diabetes. Transplantation ofthe islets has occurred using naked
islets and encapsulated islets. Naked islets require immunosuppression, whereas
encapsulated islets are protected from the immune system.
Islets are encapsulated using a wide variety ofbiocompatible polymer systems.
Calcium alginate is one of many natural polysaccharides that are used in encapsulating
islets. The commercially available form of alginate is sodium alginate which, when
added to water, forms a viscous liquid mixture. When the islet cells are added to this
viscous liquid and the mixture is dropped into a solution containing calcium chloride,
gelled beads are formed. Cells are trapped in the beads formed, providing a protective
barrier for the cells.
This project's goal is to investigate the use of this protective coating as a way of
sustaining the activity of the islets during transportation from digestion location to
transplantation location. A genetically engineered bioluminescent bacterium designated
PM6 was chosen as an initial model system in order to determine if the removal of the
cells from the encapsulation material would be likely to cause damage to the cells.
PM6 produces light during its normal growth phase with the ability to act as an
instantaneous indication of cellular activity. PM6 was encapsulated in gel beads using
calcium alginate. Later, the cells were removed from encapsulation by placing the beads
in a solution of sodium chloride. The cell density and light emitted by previously
encapsulated PM6 was compared to that ofPM6 grown under liquid culture conditions.
The lag phase is slightly longer for the encapsulated cells, but the time dependent cell
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density and light emission by the previously encapsulated bacteria are essentially the
same as that of unencapsulated PM6.
The next step of this project is to look at the stabilizing effects of removing
immortalized endothelial kidney cells from the calcium alginate. These cells are
considered more sensitive than the bacteria used in this initial study but are easier to
maintain in culture than islets. If positive results are obtained for the kidney cells, the
study will proceed to the pancreatic islet cell line.
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Background
Pancreatic Islets
Pancreatic islets are often referred to as the islets of Langerhans. These islets are
clusters of insulin producing and secreting {3 -cells found in the pancreas. Insulin is the
hormone necessary to regulate the glucose level within the body. When these {3 -cells are
destroyed by an autoimmune response, the body becomes insulin deficient. This disease
is known as Type I diabetes and accounts for five to ten percent of the diagnosed cases of
diabetes in the United States. l The number of people that suffer from Type I diabetes is
approximately 0.85 - 1.7 million. l The most prevalent treatment for Type I diabetes is
through some form of insulin dosage. Insulin must be administered daily, either through
numerous injections or by an insulin pump, in order to control the blood-glucose level.
Secondary complications, such as nephropathy, neuropathy, and cardiovascular
problems2 , can be prevented by intense insulin therapy; however, patients taking insulin
have an increased risk in experiencing hypoglycemic episodes.

Isolation of Pancreatic Islets
Warnock and Rajotte first developed the method of isolating pancreatic islets, and
Lanza et al. later modified the method. 3 .4 The pancreas is injected with cold University
of Wisconsin organ preservation solutionS and removed from the body. The organ is then
injected with a crude solution of collagenase via the pancreatic duct system. The enzyme
digests the pancreas, and the dissociated tissue is washed with cold medium. Utilizing
the density difference between the islets and the exocrine tissue, the islets are separated,
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collected, and washed several times. The separated islets are placed in either an ex -MEM
or Hams Fl2 based medium. The compact appearance of the islets is regained after
approximately 24-48 hours in culture.

Encapsulation and Transplantation of Pancreatic Islets
Whole organ transplantation of the pancreas requires an extensive surgical
procedure? Therefore, it is desirable to only transplant the insulin-producing islets.
Encapsulation of the islets into a biocompatible polymer that continue to allow the
secretion of insulin has been successful in sustaining normoglycemia. Due to the large
volume of the encapsulated islet grafts, the peritoneal cavity was designated as the ideal
transplantation site. 2 A small incision is made in the abdomen, and the encapsulated
islets are transplanted to the cavity. Encapsulation eliminates the need for
immunosuppression, and transplantation in the peritoneal cavity reduces the risks
associated with a full organ transplant. However, most of the islet transplants are still
performed using naked islets because of the lack of government approval for
encapsulated islets.
During transportation from the digestion location to the transplantation site, the
activity of some of the islets is lost due to unknown causes. These causes could be
extreme temperature variation or even shock and stress experienced while in transit. The
objective of this project is to determine if encapsulating the islets in a biocompatible
material will retain the activity of the islets during transportation. The basis of this
biocompatible material will be alginate.
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Alginate
Alginate is an anionic polysaccharide derivative of brown seaweed. Alginates
have hydro-gel forming properties with many di-, tri-, or multivalent cations. A semi
permeable gel is formed when the alginate gel is cross-linked with one of these cations.
Because of its mild gelling and good biocompatibility, alginate gel has long been used in
the food and pharmaceutical industries.? Alginates are linear copolymers of 1,4-linked
cx-L-guluronic acid (G) and {3-D-mannuronic acid (M) arranged as chains in alternating
block wise patterns. 8 The relative amounts of guluronic and mannuronic acid in the
alginate has a significant impact on porosity, swelling behavior, stability, biodegradation
ability, gel strength, immunolgoical characteristics, biocompatibility, and diffusion.

Bioluminescent Bacterium Designated PM6
Due to the lack of availability of pancreatic islet cells, the preliminary studies to
determine if the encapsulation and separation processes were harmful were performed on
a surrogate cell line. This cell line is a bioluminescent bacterium designated PM6 that
was created by researchers at Syracuse University. The bacterium is a genetically
modified bacterium that is derived from a Pseudomonad strain isolated in activated
sludge. The activated sludge microorganisms were mated with E. coli carrying the
pUTK2 plasmid. The pUTK2 plasmid contains a lux transposon and a tetracycline
resistant gene. The lux transposon contains the five genes necessary to catalyze light and
a constitutive promoter, which allows the bacterium to produce light under normal
conditions.
The reason this bacterium was chosen is because it is widely available in the
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laboratory, and other researchers working in the laboratory are familiar with growth and
assay procedures for PM6. Since the bacterium emits light under normal growing
conditions, this characteristic could be utilized in an assay that determines if the bacteria
survived the encapsulation and separation procedure.

Work Performed
Equipment and Materials Used
The cell density of the PM6 bacteria was determined using a Beckman
spectrophotometer DU520 at a wavelength of 600 nm. The light emission was measured
using a Sirius Luminometer. An Innova 4000 (New Brunswick Scientific)
incubator/shaker was used to grow the PM6 in culture. A 1.8% w/v solution of alginic
acid, sodium salt (Sigma-from macrocystis pyrifera (Kelp) low viscosity [9005-38-3])
in distilled water was the source of the alginate, and a 0.05 M solution calcium chloride
(Fischer Scientific) in distilled water served as the divalent cation used in the hydro-gel
bead formation. A 2.0 M solution of sodium chloride (Fischer Scientific) distilled water
was the source of the sodium ions to break the cross-linking between calcium and
alginate. The sodium chloride and calcium chloride solutions were pH adjusted using
hydrochloric acid and sodium hydroxide. Difco nutrient broth (Becton Dickinson)
prepared according to the instructions of the manufacturer was the growth medium used
in growing the PM6. A 2.5 g/200 mL solution of tetracycline was also used in the growth
of the bacteria. The bacterium has a tetracycline resistance gene, and the presence of
tetracycline allows the growth of the bacteria in pure culture.
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Production of a Growth and Light Emission Curve for
Unencapsulated PM6
Unencapsulated PM6 was fIrst grovm to determine a growth and light emission
curve in normal liquid culture. 100 fLL of frozen PM6 was transferred to a I L flask
containing 100 mL of an 8 giL solution of nutrient broth. 80 fLL of a 2.5 mgl 200 mL
solution of tetracycline was added to the flask. The flask was placed in the
incubator/shaker at 30°C and 200 rpm Cell density and light emission readings were
obtained every 15 minutes starting at approximately 4.5 hours from inoculation.
Readings were taken until the optical density of the solution reached 2.6-2.8.
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Figure 1: Cell density and light emission curves for unencapsulated PM6 at 30°C and
200 rpm.
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Encapsulation of PM6 Using Calcium Alginate
PM6 was grown in liquid culture following the previously mentioned procedure.
When the cells had reached an OD 600nm of approximately 0.9-1.0, the cells were cooled
to 4°C. 2 mL of the refrigerated cells were spun down and activated using I mL offresh
8 giL nutrient broth for 20 minutes. After the activation time had expired, the cells were
spun down and 500 /1L of alginate was added to the micro centrifuge tube. The mixture
was agitated to ensure the cell pellet had dissolved in the alginate.
The source of alginate used in this project was alginic acid. The divalent cation
used as the cross linking agent was Ca2+, obtained from the compound calcium chloride.
Gel beads containing encapsulated PM6 were made by dropping this 500 /1L of 1.8%
w/v solution of sodium alginate containing spun down PM6 (2 mL of OD 600 nm
refrigerated cells) from a 5 cc syringe and 23 G I" needle into a ISO mL solution of 0.05
M calcium chloride. The divalent Ca2+ cross links the alginate immediately to form a gel
bead containing encapsulated PM6. The beads and calcium chloride are stirred at 300
rpm for approximately 5 minutes to allow complete gelation.
2 Na(Alginate) + Ca2+ -7 Ca(Alginate)2 + 2 Na+
The gel beads were then removed from the calcium chloride solution by
decantation. The gel beads were placed in 200 mL of a 2.0 M solution of sodium
chloride. The sodium chloride and gel beads were stirred at 600 rpm until the PM6
separate from the gel beads. The first data set below represents a 4.5-hour interaction
time between the encapsulated PM6 and the 2.0 M sodium chloride solution. The second
set of data below represents a 2-hour interaction time between the encapsulated PM6 and
the sodium chloride. Once the cells have separated from the gel beads, the solution is
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centrifuged for 25 minutes at 12000 rpm. The sodium chloride is decanted from the
sodium alginate and PM6 remaining at the bottom of the centrifuge bottle. 100 mL of an
autociaved 8 gIL solution of nutrient broth containing 80 ~L of 2.5 g/200 mL
tetracyciine was transferred to the centrifuge bottle. The solution was agitated to ensure
the PM6 and gel were returned to a homogeneous mixture with the nutrient broth.

Production of a Growth and Light Emission Curve for
Encapsulated PM6
The nutrient broth, sodium alginate, and PM6 solution were transferred to aiL
flask and placed in the incubator/shaker at 30°C and 200 rpm. Light emission and optical
density readings were taken for the solution.
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Figure 2: Cell density and light emission curve for previously encapsulated PM6 at 30°C
and 200 rom, 4.5 hour sodium chloride interaction.
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Figure 2: Cell density and light emission curve for previously encapsulated PM6 at 30°C
and 200 rpm, 2 hour sodium chloride interaction.

Discussion of Results
The encapsulation and separation procedure used with bioluminescent bacterium
PM6 did not inhibit light production or growth. The previously encapsulated bacteria
exhibited cell density and light emission values similar to those of unencapsulated
bacteria, which can be noted from a comparison of Figure 1 and Figure 2. The previously
encapsulated bacteria were carefully examined under a microscope to determine ifthe
bacteria were present in the same form as that of unencapsulated bacteria. The cells
appeared to be the same as that of unencapsulated bacteria. If the cells were damaged in
the process, one would have expected the cells to neither produce light nor grow.
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The interaction time is a significant factor in the lag time of the bacteria. A 4.5hour interaction produced an approximately 18 hour lag phase, whereas a 2-hour
interaction time resulted in approximately a 7.5 hour lag phase. This is most likely due to
an extreme osmotic pressure gradient caused by the high salt concentration.

Recommendation for Future Work
The next cell line that needs to be studied is immortalized endothelial kidney
cells. These cells are readily available within the University of Tennessee Center for
Biotechnology. The kidney cells would be more sensitive than the bacteria used in this
study, and would provide one additional stepping-stone before encapsulation and
separation of primary pancreatic islets, which are more difficult to obtain and culture, are
examined. The form of alginic acid used in future experiments should be one that has
been purified and is preferably of a higher guluronic acid content because the guluronic
and mannuronic acid ratio directly affects the diffusion properties of the bead. 8 The
composition of the alginate affects diffusion, which will become a significant factor in
retaining the cell's activity while encapsulated. Information regarding key factors that
degrade the activity of the islets during transportation should be obtained. One may find
that encapsulation will not prevent the determined factors from negatively affecting the
activity. A source of primary islets must also be determined in order for the study to
proceed past the endothelial kidney cell line.
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Increasing the Stability of
Pancreatic Islets
J. Brock Thomas
B.S. Chemical Engineering May 2003
Mentor: Dr. Paul Frymier

Pancreatic Islet Cells
+Referred to as Islets of Langerhans
+Beta cells that secrete insulin when the
body experiences an increase in the
glucose level
+The destruction of these cells by an
autoimmune response results in Type 1
Diabetes (Insulin-Dependent)

Isolation of Pancreatic Islets
+The pancreas is infused with University
of Wisconsin organ preservation
solution
+ The organ is removed from the body
and infused with a crude solution of
collagenase
+The islets are collected using density
based purification and placed in tissue
culture

Islet Transplantation
• The isolated islets are transplanted into the
peritoneal membrane
• The immune system is suppressed to prevent
rejection of the cells

Bioartifical Pancreas
• Entrapment of the isolated cells in a
biocompatible polymer system
• Transplantation of the entrapped islets does
not require immunosuppression

Objective of Project
• Increase the survival rate of the isolated islets
during transportation from point of digestion
to pOint of transplantation
• Utilize the method used to encapsulate islets
for bioartificial transplantation to maintain the
functionality during transportation
• Exhibit that the cells retain their activity when
removed from their protective encapsulation
material

Alginate
+Serves as the biocompatible
encapsulation material
+Gels under mild physiological conditions
+Naturally occurring polysaccharide
found in brown algae
+Available commercially as alginic acid or
sodium alginate

Gelling Procedure
2 0/0 w Iv sodium alginate is dropped approximately 10
em from a syringe and needle into alSO mL 0.05 M
solution of CaCI 2
• The polymer is cross-linked to form a gel bead
• 2 Na(Alginate) + Ca++ -7 Ca(Alginate)2 + 2 Na+
•

Cell Separation
• The beads are removed from the CaCI 2 after 5 minutes
and placed in a 200 mL 2.0 M solution of NaCI
• The reverse of the above reaction occurs, and the
encapsulated cells fall out of the gel solution after
approximately one hour
• The mixture is centrifuged to separate the NaCI from the
remaining gel and cells

Cell Lines
.. PM6 Bioluminescent Bacteria
• Determine if cell separation method destroys cells
• Positive results will indicate the ability of the cells
to grow and product light after gelling, separation,
and cultue

.. Endothelial Kidney Cells
• Continue to determine if cell separation method
destroys cells
• Positive results will indicate the ability of the cells
to reattach after gelling, separation, and culture

Cell Lines (continued)
+Pancreatic Islet Cells
• Continue to determine if cell separation
method destroys the activity of the cells
• Positive results will indicate the ability of
the cells to produce insulin after gelling,
separation, and culture
• Determine if encapsulation provides
stability against the elements encountered
during transportation

PM6 Bioluminescent Bacteria
+Created through directed evolution
+Contains the luxtransposon which
catalyzes light-producing reactions
+Emits bioluminescence under normal
growing conditions

Cell Inoculation and Growth
+100 uL of frozen PM6 cells are
innoculated into 100 mL of 8 mg/mL
nutrient broth
+The innoculated cells are then
incubated and shaken at 30°C
+The growth of the bacteria and light
emmittance is exhibited in Figure 1

Figure 1: Growth Curve and Light
Emitted for PM6
f1
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Immobilized Cells Results
• 2 mL of refrigerated PM6 with an 00 of 0.9 was spun
down and mixed with 500 uL of sodium alginate
• The PM6 cells and sodium alginate were gelled
• The cells were removed out of encapsulation using
sodium chloride and placed in growth medium
• Figure 2 represents the growth curve and light
emitted for PM6 after having been encapsulated and
released from the calcium alginate
• Lag phase is increased, but growth and light emitted
follows the same pattern as cultured cells

Figure 2: Growth Curve and Light Emitte
for Encapsulated PM6
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Conclusions
.. Gelling and separation of cells does not
destroy the activity and the viability of the
PM6 bioluminescent bacteria
.. Encapsulated cells exhibit similar growth and
light emitted patterns as those that are
cultured
.. Endothelial kidney cells will now be
encapsulated to determine if a more sensitive
cell line can withstand the cell separation step
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Figure I: Cell density and light emission curves for unencapsulated PM6 at 30°C and
200 rpm.

Encapsulation of PM6 Using Calcium Alginate

~own in liquid culture fo llowing the previously mentioned procedure.

PM6r

When the

cel~reached an OD600nm of approximately 0.9-1.0, the cells were cooled

to 4°C. 2 mL ofthe\\efrigerated cells were spun down and activated using I mL of fresh
\

8 gIL nutrient broth for~O minutes. After the activation time had expired, the cells were
\\

spun down and 500 f-LL

of~ginate

,,

was added to the micro centrifuge tube. The mixture

\

~

}jas agitated to ensure the cell

~~ ~

llet had dissolved in the alginate.

(The source of alginat use . this project was alginic acid. The divalent cation

used as the cross linking agent was Ca

Gel beads containing encapsulated PM

obtained from the compound calcium chloride.
e

w/v solution of sodium alginate containing sp

ade by dropping this 500 /1L of 1.8%
d
P
own M6 (2 mL ofOD6DDnm

o

